Total Revenue |
350.02B |
307.39B |
282.84B |
Cost of Revenue |
146.31B |
133.33B |
126.2B |
Gross Profit |
203.71B |
174.06B |
156.63B |
Operating Expenses |
91.32B |
89.77B |
81.79B |
Research and Development |
49.33B |
45.43B |
39.5B |
Selling, General & Administrative Expenses |
42B |
44.34B |
42.29B |
Selling & Marketing Expenses |
27.81B |
27.92B |
26.57B |
General & Administrative Expenses |
14.19B |
16.43B |
15.72B |
Other Expenses |
0 |
0 |
-3.51B |
Operating Income |
112.39B |
84.29B |
74.84B |
Total Other Income/Expenses Net |
7.43B |
1.42B |
-3.51B |
Income Before Tax |
119.82B |
85.72B |
71.33B |
Income Tax |
19.7B |
11.92B |
11.36B |
Net Income |
100.12B |
73.8B |
59.97B |
Basic EPS |
8.04 |
5.84 |
4.59 |
EPS Diluted |
8.04 |
5.8 |
4.56 |
Basic Average Shares |
12.45B |
12.63B |
13.06B |
Diluted Average Shares |
12.45B |
12.72B |
13.16B |
EBITDA |
112.39B |
97.97B |
91.33B |